Urinary Bladder Matrix (UBM) Registry

StatusNot Yet Recruiting
PhaseNot specified
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
The purpose of this registry is to collect real-world information on patients treated with Urinary Bladder Matrix (UBM) products. The study will evaluate patient characteristics, treatment patterns, and clinical outcomes to better understand how UBM products are used in routine clinical practice and the outcomes experienced by patients over time.
Trial Details
NCT Number NCT07805798
Lead Sponsor Integra LifeSciences Corporation
Conditions
(from sponsor)		 Tissue Repair, Soft Tissue Reconstruction, Wound Management, Pressure Ulcer (PU), Necrotizing Soft Tissue Infection, Fournier's Gangrene, Pilonidal Cyst, Open Abdomen +3 more
Related terms Fournier Gangrene, Hidradenitis Suppurativa, Pilonidal Sinus, Pressure Ulcer, Surgical Wound
Enrollment 300 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov